The Latest Breaking News from Allergy

It's summer, which means most of us are out looking for the best place to catch some sun. But some people are allergic to sunlight - these are the common signs and treatment options for sun allergy

Condition triggered by large amounts of tiny pollen particles becoming airborne

DBV Technologies (NASDAQ: DBVT) announced positive topline results from EPITOPE study of its drug candidate Viaskin Peanut 250 µg for the treatment of peanut-allergic toddlers ages 1 to 3 years.

Many could be forced to give Jubilee celebrations a miss after Edinburgh locals are warned of a 'pollen bomb' due to hit over the weekend - tree and grass pollen are the common culprits for sneezing fits and itchy eyes.

The food standards regulator has warned shoppers not to eat either of the affected products.

Products have been pulled from sale due to issues including potential salmonella, undeclared allergens and safety concerns

Anyone with any of the below items should visit their nearest supermarket for a full refund or exchange

Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) determined that the evaluation of NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Zyesami (aviptadil) should cease due to futility. Aviptadil was the sole remaining investigational medicine in ACTIV-3b targeted at critical-ill COVID-19 patients. ACTIV-3b study evaluated Zyesami and Gilead Sciences Inc's (NASDAQ:GILD) Veklury (remdesivir)…

Due to the presence of almonds, the croissants pose a health risk to anyone who has a nut allergy.